VALCYTE Side Effects

6928257-3 | Headache, Herpes Simplex
on Aug 12, 2010 Male patient from GERMANY , weighting 143.3 lb, was diagnosed with prophylaxis against graft versus host disease, antifungal prophylaxis and was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), herpes simplex (What is herpes simplex?). Valcyte dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), COTRIM (View Cotrim Review and Cotrim Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), POSACONAZOLE (View Posaconazole Review and Posaconazole Label ). Patient was hospitalized.

6916759-5 | Headache, Herpes Simplex
Patient was taking Valcyte (View Usage). Patient had the following side effects: headache (What is headache?), herpes simplex (What is herpes simplex?) on Aug 04, 2010 from GERMANY Additional patient health information: Male patient , 41 years of age, was diagnosed with infection prophylaxis and. Valcyte dosage: . Patient was hospitalized.

6767714-X | Ankle Fracture, Decreased Appetite, Weight Decreased
Adverse event was reported on Jun 02, 2010 by a Female patient taking Valcyte (View Usage) (Dosage: ) was diagnosed with epstein-barr virus infection, prophylaxis, immunosuppression, hypertension and. Location: UNITED STATES , weighting 65.70 lb, After Valcyte was administered, patient had the following side effects: ankle fracture, decreased appetite, weight decreased. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), BACTRIM (Indication:uti Prophylaxis) (View Bactrim Review and Bactrim Label ), PROGRAF (View Prograf Review and Prograf Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FERREX (View Ferrex Review and Ferrex Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6718385-X | Anaemia, Anaemia Haemolytic Autoimmune, Bone Marrow Disorder, Bone Marrow Failure, Clostridium Difficile Colitis, Febrile Neutropenia, Infection, Leukopenia, Mesenteric Vein Thrombosis
on May 05, 2010 Male patient from FINLAND , 62 years of age, was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anaemia haemolytic autoimmune, bone marrow disorder, bone marrow failure, clostridium difficile colitis, febrile neutropenia, infection (What is infection?), leukopenia, mesenteric vein thrombosis. Valcyte dosage: 2 Tablets Two Times A Day = 1800 Mg. During the same period patient was treated with MABTHERA (Dosage: 375 Mg/m2 Followed By 500 Mg/m2; Form: Infusion) (View Mabthera Review and Mabthera Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), BENDAMUSTINE (View Bendamustine Review and Bendamustine Label ), MABCAMPATH (View Mabcampath Review and Mabcampath Label ). Patient was hospitalized.


6684489-3 | Leukopenia, Pneumocystis Jiroveci Pneumonia
on Apr 13, 2010 Male patient from UNITED KINGDOM , weighting 171.3 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), cardiovascular event prophylaxis, aplasia pure red cell and was treated with Valcyte (View Usage). Patient had the following side effects: leukopenia, pneumocystis jiroveci pneumonia. Valcyte dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), TACROLIMUS (5 Mg Am And 4 Mg Pm) (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), AF37702 (View Af37702 Review and Af37702 Label ). Patient was hospitalized.

6634504-8 | Aspergillosis, Skin Cancer
Patient was taking Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: aspergillosis, skin cancer (What is skin cancer?) on Mar 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 175.0 lb, was diagnosed with lung transplant (What is lung transplant?) and. Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6532571-3 | Hepatic Failure, Jaundice Cholestatic, Liver Function Test Abnormal
Adverse event was reported on Jan 06, 2010 by a Male patient taking Valcyte (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure, jaundice cholestatic, liver function test abnormal.

6349560-4 | Blood Urine Present, Haemolytic Anaemia, Thrombocytopenia, Transplant Rejection, Tubulointerstitial Nephritis
on Sep 10, 2009 Male patient from GERMANY , weighting 207.9 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), renal transplant and was treated with Valcyte (View Usage). Patient had the following side effects: blood urine present, haemolytic anaemia, thrombocytopenia, transplant rejection, tubulointerstitial nephritis. Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ALEFACEPT (Route: Intravenous (nos)) (View Alefacept Review and Alefacept Label ), PLAVIX (View Plavix Review and Plavix Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

6342846-9 | Blood Urine Present, Haemolytic Anaemia, Thrombocytopenia, Transplant Rejection, Tubulointerstitial Nephritis
on Sep 01, 2009 Male patient from GERMANY , weighting 207.9 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), renal transplant and was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: blood urine present, haemolytic anaemia, thrombocytopenia, transplant rejection, tubulointerstitial nephritis. Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ALEFACEPT (Route: Intravenous (nos)) (View Alefacept Review and Alefacept Label ), PLAVIX (View Plavix Review and Plavix Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

6313174-2 | Cytomegalovirus Infection, Myopathy, Transplant Rejection
Patient was taking Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus infection (What is cytomegalovirus infection?), myopathy, transplant rejection on Aug 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with immunosuppression and. Valcyte dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CP 690550 (View Cp-690550 Review and Cp-690550 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6311174-X | Blood Urine Present, Thrombocytopenia
Adverse event was reported on Aug 13, 2009 by a Male patient taking Valcyte (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), renal transplant and. Location: GERMANY , weighting 207.9 lb, Patient had the following side effects: blood urine present, thrombocytopenia. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), ALEFACEPT (Route: Intravenous (nos)) (View Alefacept Review and Alefacept Label ), PROGRAF (View Prograf Review and Prograf Label ), PLAVIX (View Plavix Review and Plavix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6309381-5 | Blood Urine Present, Thrombocytopenia
on Aug 10, 2009 Male patient from GERMANY , weighting 207.9 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), renal transplant and was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: blood urine present, thrombocytopenia. Valcyte dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), ALEFACEPT (Route: Intravenous (nos)) (View Alefacept Review and Alefacept Label ), PROGRAF (View Prograf Review and Prograf Label ), PLAVIX (View Plavix Review and Plavix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6295839-4 | Pneumonitis
on Jul 28, 2009 Male patient from MEXICO , child 11 years of age, was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis. Valcyte dosage: . Patient was hospitalized.

6288002-4 | T-lymphocyte Count Decreased
Patient was taking Valcyte (View Usage). Patient had the following side effects: t-lymphocyte count decreased on Jul 21, 2009 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Valcyte dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), ISENTRESS (View Isentress Review and Isentress Label ).

6286126-9 | Pneumonitis
Adverse event was reported on Jul 24, 2009 by a Male patient taking Valcyte (View Usage) (Dosage: ) . Location: MEXICO , child 11 years of age, After Valcyte was administered, patient had the following side effects: pneumonitis. Patient was hospitalized.

6282453-X | Pneumonitis
on Jul 21, 2009 Female patient from MEXICO , child 11 years of age, was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis. Valcyte dosage: .

6209455-3 | T-lymphocyte Count Decreased
on May 22, 2009 Male patient from UNITED STATES , 46 years of age, was treated with Valcyte (View Usage). Patient had the following side effects: t-lymphocyte count decreased. Valcyte dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), ISENTRESS (View Isentress Review and Isentress Label ).

6207114-4 | White Blood Cell Count Decreased
Patient was taking Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: white blood cell count decreased on Mar 03, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, . Valcyte dosage: 900 Mg Daily. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), DOFETILIDE (View Dofetilide Review and Dofetilide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CRESTOR (View Crestor Review and Crestor Label ), MAG OX (MAGNESIUM OXIDE) (View Mag-ox (magnesium Oxide) Review and Mag-ox (magnesium Oxide) Label ). Patient was hospitalized.

6207113-2 | No Adverse Event, Overdose
Adverse event was reported on Oct 22, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: 3150 Mg) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: no adverse event, overdose. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COREG (View Coreg Review and Coreg Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6152660-5 | Epstein-barr Virus Associated Lymphoproliferative Disorder, Neutropenia
on Apr 03, 2009 Male patient from DENMARK , weighting 40.34 lb, was diagnosed with immunosuppression and was treated with Valcyte (View Usage). Patient had the following side effects: epstein-barr virus associated lymphoproliferative disorder, neutropenia. Valcyte dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF (Dose Was Gradually Reduced; Highest Dose Given 2.8 Mg Daily) (View Prograf Review and Prograf Label ), CYMEVENE (View Cymevene Review and Cymevene Label ), PREDNISOLONE (Once Daily) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6128148-4 | Anaemia, B-cell Lymphoma
on Mar 11, 2009 Female patient from IRAN (ISLAMIC REPUBLIC OF) , 62 years of age, was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: anaemia, b-cell lymphoma. Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ).

6092810-2 | Lymph Node Tuberculosis
Patient was taking Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: lymph node tuberculosis on Feb 12, 2009 from GERMANY Additional patient health information: Male patient , 48 years of age, weighting 188.5 lb, . Valcyte dosage: Frequency Alternately 1 Per 1 Day And 2 Per 1 Day.. During the same period patient was treated with NEPHROTRANS (View Nephrotrans Review and Nephrotrans Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PROGRAF (View Prograf Review and Prograf Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), COTRIM (View Cotrim Review and Cotrim Label ), MAGNESIUM VERLA (View Magnesium Verla Review and Magnesium Verla Label ). Patient was hospitalized.

6051705-0 |
Adverse event was reported on Jan 13, 2009 by a Female patient taking Valcyte (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 81 years of age, .

6018080-9 | Deafness Unilateral, Visual Acuity Reduced
on Dec 12, 2008 Female patient from UNITED STATES , child 11 years of age, was diagnosed with renal transplant and was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: deafness unilateral, visual acuity reduced. Valcyte dosage: Other Indication: Epstein-barr Virus (ebv). During the same period patient was treated with GENGRAF (View Gengraf Review and Gengraf Label ), NEXIUM (View Nexium Review and Nexium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), IRON (View Iron Review and Iron Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), SULFONAMIDE NOS (Sulfa) (View Sulfonamide Nos Review and Sulfonamide Nos Label ).

5976037-8 | Osteonecrosis
on Nov 20, 2008 Female patient from SPAIN , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Valcyte dosage: . During the same period patient was treated with EMEPROTON (View Emeproton Review and Emeproton Label ), KIVEXA (Strenght: 600 Mg/300 Mg Film Coated Tablet.) (View Kivexa Review and Kivexa Label ), LIPLAT (View Liplat Review and Liplat Label ), SEPTRIN (View Septrin Review and Septrin Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5976035-4 | Osteonecrosis
Patient was taking Valcyte (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Nov 20, 2008 from SPAIN Additional patient health information: Male patient , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Valcyte dosage: Form Reported As Film Coated Tabs.. During the same period patient was treated with EMEPROTON (View Emeproton Review and Emeproton Label ), KIVEXA (Form Reported As Film Coated Tabs And Strength Reported As 600/300 Mg.) (View Kivexa Review and Kivexa Label ), LIPLAT (View Liplat Review and Liplat Label ), SEPTRIN (View Septrin Review and Septrin Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5953259-3 | Anorexia, Asthenia, Diarrhoea, Nausea, Skin Cancer, Weight Decreased
Adverse event was reported on Nov 04, 2008 by a Female patient taking Valcyte (View Usage) (Dosage: Dose: One Dose Form Daily) . Location: UNITED STATES , 64 years of age, After Valcyte was administered, patient had the following side effects: anorexia, asthenia, diarrhoea, nausea (What is nausea?), skin cancer (What is skin cancer?), weight decreased. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), XIFAXAN (View Xifaxan Review and Xifaxan Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VASOTEC (View Vasotec Review and Vasotec Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM (View Calcium Review and Calcium Label ), EVISTA (View Evista Review and Evista Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5944720-6 | Hepatic Failure, Renal Failure
on Oct 30, 2008 Male patient from SWEDEN , 67 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, renal failure. Valcyte dosage: Dosing Amount Was Reported As Dose 900 Mgx2. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FOLACIN (View Folacin Review and Folacin Label ), KONAKION (View Konakion Review and Konakion Label ), FLAGYL (View Flagyl Review and Flagyl Label ), SODIUM POLYSTYRENE SULFONATE (View Sodium Polystyrene Sulfonate Review and Sodium Polystyrene Sulfonate Label ), ORALOVITE (View Oralovite Review and Oralovite Label ).

5943234-7 | Osteonecrosis
on Oct 28, 2008 Female patient from SPAIN , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Valcyte (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Valcyte dosage: . During the same period patient was treated with EMEPROTON (View Emeproton Review and Emeproton Label ), KIVEXA (Strenght: 600 Mg/300 Mg Film Coated Tablet.) (View Kivexa Review and Kivexa Label ), LIPLAT (View Liplat Review and Liplat Label ), SEPTRIN (View Septrin Review and Septrin Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5943233-5 | Osteonecrosis
Patient was taking Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?) on Oct 28, 2008 from SPAIN Additional patient health information: Male patient , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Valcyte dosage: Form Reported As Film Coated Tabs.. During the same period patient was treated with EMEPROTON (View Emeproton Review and Emeproton Label ), KIVEXA (Form Reported As Film Coated Tabs And Strength Reported As 600/300 Mg.) (View Kivexa Review and Kivexa Label ), LIPLAT (View Liplat Review and Liplat Label ), SEPTRIN (View Septrin Review and Septrin Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5937892-0 | Hepatic Failure, Renal Failure
Adverse event was reported on Oct 23, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: Dosing Amount Was Reported As Dose 900 Mgx2) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: SWEDEN , 67 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure, renal failure. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FOLACIN (View Folacin Review and Folacin Label ), KONAKION (View Konakion Review and Konakion Label ), FLAGYL (View Flagyl Review and Flagyl Label ), SODIUM POLYSTYRENE SULFONATE (View Sodium Polystyrene Sulfonate Review and Sodium Polystyrene Sulfonate Label ), ORALOVITE (View Oralovite Review and Oralovite Label ).

5927622-0 | Anorexia, Asthenia, Diarrhoea, Nausea, Skin Cancer, Weight Decreased
on Oct 15, 2008 Female patient from UNITED STATES , 64 years of age, was treated with Valcyte (View Usage). Patient had the following side effects: anorexia, asthenia, diarrhoea, nausea (What is nausea?), skin cancer (What is skin cancer?), weight decreased. Valcyte dosage: Dose: One Dose Form Daily. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), XIFAXAN (View Xifaxan Review and Xifaxan Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VASOTEC (View Vasotec Review and Vasotec Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CALCIUM (View Calcium Review and Calcium Label ), EVISTA (View Evista Review and Evista Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5923906-0 | Disease Recurrence, Pyrexia
on Oct 11, 2008 Male patient from IRAN (ISLAMIC REPUBLIC OF) , 27 years of age, was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: disease recurrence, pyrexia. Valcyte dosage: For 28 Days. During the same period patient was treated with CYMEVENE (Strength Is : 500mg And Formulation Is : 10 Ml/vial) (View Cymevene Review and Cymevene Label ). Patient was hospitalized.

5916648-9 | Disease Recurrence, Pyrexia
Patient was taking Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, pyrexia on Oct 05, 2008 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Male patient , 27 years of age, . Valcyte dosage: For 28 Days. During the same period patient was treated with CYMEVENE (Strength Is : 500mg And Formulation Is : 10 Ml/vial) (View Cymevene Review and Cymevene Label ). Patient was hospitalized.

5822407-8 | Eye Disorder
Adverse event was reported on Jul 17, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: ) . Location: UNITED STATES , 34 years of age, Patient had the following side effects: eye disorder. During the same period patient was treated with ENTECAVIR (View Entecavir Review and Entecavir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

5818998-3 | White Blood Cell Count Decreased
on Jul 21, 2008 Female patient from UNITED STATES , weighting 149.3 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), renal transplant and was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: white blood cell count decreased. Valcyte dosage: 450 Mg Daily -ng Tube- Other. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PROGRAF ORAL SUSP (View Prograf Oral Susp Review and Prograf Oral Susp Label ), IMMUNE GOBULIN HUMAN IVIG (View Immune Gobulin Human Ivig Review and Immune Gobulin Human Ivig Label ). Patient was hospitalized.

5762469-X | Asthenia, Hyperglycaemia
on Jun 08, 2007 Male patient from UNITED STATES , 50 years of age, was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hyperglycaemia. Valcyte dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PROCARDIA XL (View Procardia Xl Review and Procardia Xl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VITAMIN E (ALPHA TOCOPHEROL) (View Vitamin E (alpha-tocopherol) Review and Vitamin E (alpha-tocopherol) Label ), PROTONIX (View Protonix Review and Protonix Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ENTERIC COATED ASA (ASPIRIN) (View Enteric Coated Asa (aspirin) Review and Enteric Coated Asa (aspirin) Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5762468-8 | Renal Failure Acute
Patient was taking Valcyte (View Usage). Patient had the following side effects: renal failure acute on May 25, 2007 from UNITED STATES Additional patient health information: Male patient , 30 years of age, . Valcyte dosage: .

5762369-5 | Disease Progression
Adverse event was reported on May 30, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: ) . Location: UNITED STATES , 45 years of age, After Valcyte was administered, patient had the following side effects: disease progression. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PROZAC (View Prozac Review and Prozac Label ).

5724994-7 | Bone Marrow Failure, Cerebrovascular Accident, Sepsis, Transplant Rejection
on Apr 16, 2008 Male patient from MEXICO , weighting 110.2 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression, hypertension and was treated with Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, cerebrovascular accident, sepsis (What is sepsis?), transplant rejection. Valcyte dosage: . During the same period patient was treated with PREDNISONA (Dosage Reported: Daily) (View Prednisona Review and Prednisona Label ), TACROLIMUS (Dosage: Daily) (View Tacrolimus Review and Tacrolimus Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5724710-9 | Disease Progression
on Apr 24, 2008 Male patient from UNITED STATES , 45 years of age, was treated with Valcyte (View Usage). Patient had the following side effects: disease progression. Valcyte dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PROZAC (View Prozac Review and Prozac Label ).

5718206-8 | Bone Marrow Failure, Cerebrovascular Accident, Sepsis, Transplant Rejection
Patient was taking Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: bone marrow failure, cerebrovascular accident, sepsis (What is sepsis?), transplant rejection on Apr 16, 2008 from MEXICO Additional patient health information: Male patient , weighting 110.2 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression, hypertension and. Valcyte dosage: . During the same period patient was treated with PREDNISONA (Dosage Reported: Daily) (View Prednisona Review and Prednisona Label ), TACROLIMUS (Dosage: Daily) (View Tacrolimus Review and Tacrolimus Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5703281-7 | Bone Marrow Failure, Cerebrovascular Accident, Leukopenia, Transplant Rejection
Adverse event was reported on Apr 01, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression, hypertension and. Location: MEXICO , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, cerebrovascular accident, leukopenia, transplant rejection. During the same period patient was treated with PREDNISONA (Dosage Reported: Daily) (View Prednisona Review and Prednisona Label ), TACROLIMUS (Dosage: Daily) (View Tacrolimus Review and Tacrolimus Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

5690352-7 |
on Jun 12, 2003 Male patient from UNITED STATES , 57 years of age, was treated with Valcyte (View Usage). . Valcyte dosage: .

5689249-8 | Bone Marrow Failure, Leukopenia, Transplant Rejection
on Mar 19, 2008 Male patient from MEXICO , 23 years of age, was diagnosed with transplant and was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: bone marrow failure, leukopenia, transplant rejection. Valcyte dosage: . During the same period patient was treated with PREDNISONA (View Prednisona Review and Prednisona Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

5688955-9 | Leukopenia
Patient was taking Valcyte (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia on Apr 18, 2007 from GERMANY Additional patient health information: Male patient , 50 years of age, weighting 147.7 lb, . Valcyte dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

5633300-8 | Blood Pressure Decreased, Heart Rate Decreased
Adverse event was reported on Feb 11, 2008 by a Male patient taking Valcyte (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: blood pressure decreased, heart rate decreased. Patient was hospitalized.

5591164-5 | Sepsis
on Jan 08, 2008 Male patient from UNITED STATES , 37 years of age, was treated with Valcyte (View Usage). After Valcyte was administered, patient had the following side effects: sepsis (What is sepsis?). Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

5589444-2 |
on Jan 07, 2008 Female patient from UNITED STATES , 45 years of age, was treated with Valcyte (View Usage). . Valcyte dosage: .

5584053-3 | Sepsis
Patient was taking Valcyte (View Usage). Patient had the following side effects: sepsis (What is sepsis?) on Jan 03, 2008 from UNITED STATES Additional patient health information: Male patient , 37 years of age, . Valcyte dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ).